What happened
Researchers from The University of Texas MD Anderson Cancer Center presented an AI-guided technique at the Society of NeuroInterventional Surgery's 23rd Annual Meeting, enhancing targeted therapy delivery for malignant brain tumours. The AI identifies all tumour-feeding arterial pedicles, enabling physicians to deliver tailored therapy to each vessel. This multi-pedicle approach achieved over 85% tumour coverage in three patients, significantly exceeding the less than 65% coverage from traditional single-artery methods, and proved safely repeatable.
Why it matters
This advancement offers neurointerventional oncologists a mechanism for more precise, personalised brain tumour treatment. The metric of over 85% tumour coverage, compared to under 65% with previous methods, indicates a substantial improvement in delivery efficacy. For procurement teams, this signals a future need for AI-integrated imaging and delivery systems, potentially shifting investment towards solutions that optimise patient-specific anatomical mapping. This follows other recent AI applications in neuro-oncology, such as AI predicting brain barrier opening safely.
